Cybin (HELP) Goodwill & Intangibles (2021 - 2025)
Cybin (HELP) reported Goodwill & Intangibles of $64.5 million for Q1 2025, up 4.74% on a YoY basis from $61.6 million in Q1 2024, and up 5.12% quarter-over-quarter from $61.3 million in Q4 2024.
Cybin (HELP) Goodwill & Intangibles (2021 - 2025) Analysis & Trends
Cybin has reported Goodwill & Intangibles for 5 years, with the latest figure at $64.5 million in Q1 2025.
- For the quarter ending Q1 2025, Goodwill & Intangibles rose 4.74% year-over-year to $64.5 million; the trailing twelve-month figure through Mar 2025 stood at $64.5 million (up 4.74% YoY), and the FY2025 full-year result was $66.5 million, up 8.11% from the prior year.
- Goodwill & Intangibles for Q1 2025 stood at $64.5 million, up from $61.3 million in the prior quarter.
- The five-year high for Goodwill & Intangibles was $64.5 million in Q1 2025, with the low at $19.7 million in Q1 2021.
- Historically, Goodwill & Intangibles has averaged $39.6 million across 5 years, with a median of $30.5 million in 2023.
- Annual changes were most pronounced in 2023 — Goodwill & Intangibles dropped 1.76% — and 2024, when it surged 168.04%.
- Cybin's Goodwill & Intangibles stood at $20.0 million in 2021, then gained by 10.68% to $22.2 million in 2022, then jumped by 166.31% to $59.0 million in 2023, then climbed by 3.91% to $61.3 million in 2024, then rose by 5.12% to $64.5 million in 2025.
- The last three Goodwill & Intangibles figures came in at $64.5 million (Q1 2025), $61.3 million (Q4 2024), and $61.1 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Cybin | 75.42 Mn | 75.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 64.47 Mn |
| Dec 31, 2024 | 61.33 Mn |
| Sep 30, 2024 | 61.08 Mn |
| Jun 30, 2024 | 61.01 Mn |
| Mar 31, 2024 | 61.55 Mn |
| Dec 31, 2023 | 59.02 Mn |
| Sep 30, 2023 | 22.79 Mn |
| Jun 30, 2023 | 37.86 Mn |
| Dec 31, 2022 | 22.16 Mn |
| Sep 30, 2022 | 23.20 Mn |
| Dec 31, 2021 | 20.02 Mn |
| Sep 30, 2021 | 20.03 Mn |
| Jun 30, 2021 | 19.90 Mn |
| Mar 31, 2021 | 19.73 Mn |